[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100459654":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":29,"responsibleParty":77,"collaborators":10,"id":80,"slug":10,"hasResults":81,"nctId":82,"briefTitle":83,"officialTitle":83,"acronym":10,"eligibilityCriteria":84,"healthyVolunteers":81,"sex":85,"minAge":86,"maxAge":10,"enrollmentInfo":87,"targetDuration":10,"studyType":90,"phases":10,"briefSummary":91,"conditions":92,"keywords":96,"overallStatus":32,"whyStopped":10,"lastUpdateSubmitDate":100,"lastUpdatePostDateStruct":101,"startDateStruct":104,"completionDateStruct":106,"leadSponsor":108,"locationsCount":109},{"fullName":5,"class":6},"Dana-Farber Cancer Institute","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Data\u002FBiospecimen Collection",null,"Tumor and saliva specimens from participants with non-small cell lung cancer (NSCLC) or small cell lung cancer (SCLC) diagnosed at age 45 or younger",[13],"Genetic: Data and Specimen Collection",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"GENETIC","Data and Specimen Collection","* Provide research team access to relevant medical records\n* Answer two (2) short questionnaires at time of consent\n* Provide up to 5 tubes (37 ml) of blood at or near the time of consent, and\u002For saliva sample\n* Consider consenting to other optional parts of the research such as:\n\n  * Providing additional blood or tissue samples in the future (optional)\n  * Providing permission for obtainment of stored tissue specimens from lung cancer surgeries or biopsies from the pathology departments where they have been stored (optional)",[9],[21],{"name":22,"affiliation":5,"role":23},"Pasi A Janne, MD, PhD","PRINCIPAL_INVESTIGATOR",[25],{"name":22,"role":26,"phone":27,"phoneExt":10,"email":28},"CONTACT","617-632-6036","Pasi_Janne@dfci.harvard.edu",[30,50,62,70],{"facility":31,"status":32,"city":33,"state":34,"zip":35,"country":36,"cosmosGeoPoint":37,"geoPoint":42,"contacts":43},"Massachusetts General Hospital","RECRUITING","Boston","Massachusetts","02114","United States",{"type":38,"coordinates":39},"Point",[40,41],-71.05977,42.35843,{"lat":41,"lon":40},[44,48],{"name":45,"role":26,"phone":46,"phoneExt":10,"email":47},"Jessica Line, MD","617-724-1134","jjlin1@partners.org",{"name":49,"role":23,"phone":10,"phoneExt":10,"email":10},"Jessica Lin, MD",{"facility":51,"status":52,"city":33,"state":34,"zip":53,"country":36,"cosmosGeoPoint":54,"geoPoint":56,"contacts":57},"Beth Israel Deaconess Medical Center","NOT_YET_RECRUITING","02115",{"type":38,"coordinates":55},[40,41],{"lat":41,"lon":40},[58,61],{"name":59,"role":26,"phone":60,"phoneExt":10,"email":10},"Daniel Costa, MD PhD","617-667-9236",{"name":59,"role":23,"phone":10,"phoneExt":10,"email":10},{"facility":63,"status":52,"city":33,"state":34,"zip":53,"country":36,"cosmosGeoPoint":64,"geoPoint":66,"contacts":67},"Brigham and Women's Hospital",{"type":38,"coordinates":65},[40,41],{"lat":41,"lon":40},[68,69],{"name":22,"role":26,"phone":27,"phoneExt":10,"email":28},{"name":22,"role":23,"phone":10,"phoneExt":10,"email":10},{"facility":5,"status":32,"city":33,"state":34,"zip":53,"country":36,"cosmosGeoPoint":71,"geoPoint":73,"contacts":74},{"type":38,"coordinates":72},[40,41],{"lat":41,"lon":40},[75,76],{"name":22,"role":26,"phone":27,"phoneExt":10,"email":28},{"name":22,"role":23,"phone":10,"phoneExt":10,"email":10},{"type":23,"investigatorFullName":78,"investigatorTitle":79,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Pasi Janne, MD, PhD","Principal Investigator","100459654",false,"NCT05265429","Biology of Young Lung Cancer Study: The YOUNG LUNG Study","Inclusion Criteria:\n\n* Age 45 and under at lung cancer diagnosis\n* Pathologically confirmed bronchogenic lung carcinoma (NSCLC or SCLC of any stage) at any treatment time point\n* Provision of written informed consent\n* Willingness to undergo no more than two (2) peripheral blood draws in a four (4) week period, with no more than 50 ml peripheral blood collected over eight (8) weeks\n* Individuals under age 18 are eligible for study if they meet defined criteria; in addition, consent for participation must be given by a legal guardian or parent\n\nExclusion Criteria:\n\n* Individuals who decline to sign consent\n* Individuals who are unable to give consent or assent and are without a designated healthcare proxy\n* Compromise of patient diagnosis or staging if tissue is used for research","ALL","15 Years",{"count":88,"type":89},500,"ESTIMATED","OBSERVATIONAL","The purpose of this research study is to learn more about lung cancer (NSCLC or SCLC) diagnosed in adults at ages 45 or younger.",[93,94,95],"Non Small Cell Lung Cancer","Small Cell Lung Carcinoma","NUT Carcinoma",[93,94,97,98,99],"Genetics","Genomics","Young lung cancer","2025-10-28",{"date":102,"type":103},"2025-10-29","ACTUAL",{"date":105,"type":103},"2023-01-01",{"date":107,"type":89},"2027-08-01",{"name":5,"class":6},4]